Intra-body dynamics of d-serine reflects the origin of kidney diseases
Tóm tắt
d-Serine, present only in trace amounts in humans, is now recognized as a biomarker of chronic kidney disease (CKD). CKD is heterogeneous in its original kidney diseases, whose diagnoses require kidney biopsy. In this study, we examined whether the intra-body dynamics of d-serine, indexed by its blood and urinary levels, reflects the origin of kidney diseases. Patients with six kinds of kidney disease undergoing kidney biopsy were enrolled in a single center. Levels of d- and l-serine were measured using two-dimensional high-performance liquid chromatography. The associations between the origin of kidney diseases and the intra-body dynamics of d-serine were examined using multivariate cluster analyses. Unlike the non-CKD profile, patients with CKD showed broadly-distributed profiles of intra-body dynamics of d-serine. The plasma level of d-serine plays a key role in the detection of kidney diseases, whereas a combination of plasma and urinary levels of d-serine distinguished the origin of CKD, especially lupus nephritis. Intra-body dynamics of d-serine have the potential to predict the origin of kidney diseases. Monitoring of d-serine may guide specific treatments for the origin of kidney diseases.
Tài liệu tham khảo
Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156–63.
International Society of Nephrology. The under-recognized epidemic: worldwide, over 850 million people suffer from kidney diseases. 2018. https://www.theisn.org/images/ASN_PR_20180627_Final6.26.18Press_E.pdf. Accessed 1 Oct 2018.
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–59.
Hogan JJ, Mocanu M, Berns JS. The native kidney biopsy: update and evidence for best practice. Clin J Am Soc Nephrol. 2016;11:354–62.
Srivastava A, Palsson R, Kaze AD, Chen ME, Palacios P, Sabbisetti V, et al. The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston kidney biopsy cohort study. J Am Soc Nephrol. 2018;29:2213–24.
Kimura T, Hamase K, Miyoshi Y, Yamamoto R, Yasuda K, Mita M, et al. Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease. Sci Rep. 2016;6:26137.
Hesaka A, Sakai S, Hamase K, Ikeda T, Matsui R, Mita M, et al. d-Serine reflects kidney function and diseases. Sci Rep. 2019;9:5104.
Hesaka A, Yasuda K, Sakai S, Yonishi H, Namba-Hamano T, Takahashi A, et al. Dynamics of d-serine reflected the recovery course of a patient with rapidly progressive glomerulonephritis. CEN Case Rep. 2019;8:297–300.
Kimura T, Hesaka A, Isaka Y. d-Amino acids and kidney diseases. Clin Exp Nephrol. 2020;24:404–10.
Krebs HA. Metabolism of amino-acids: deamination of amino-acids. Biochem J. 1935;29:1620–44.
Hashimoto A, Nishikawa T, Hayashi T, Fujii N, Harada K, Oka T, et al. The presence of free d-serine in rat brain. FEBS Lett. 1992;296:33–6.
Miyoshi Y, Hamase K, Tojo Y, Mita M, Konno R, Zaitsu K. Determination of d-serine and d-alanine in the tissues and physiological fluids of mice with various d-amino-acid oxidase activities using two-dimensional high-performance liquid chromatography with fluorescence detection. J Chromatogr B. 2009;877:2506–12.
Hamase K, Miyoshi Y, Ueno K, Han H, Hirano J, Morikawa A, et al. Simultaneous determination of hydrophilic amino acid enantiomers in mammalian tissues and physiological fluids applying a fully automated micro-two-dimensional high-performance liquid chromatographic concept. J Chromatogr A. 2010;1217:1056–62.
Kimura T, Hesaka A, Isaka Y. Utility of d-serine monitoring in kidney disease. Biochim Biophys Acta Proteins Proteom. 2020;1868:140449.
Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521–30.
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630–40.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
Hamase K, Ikeda T, Ishii C, Ishigo S, Masuyama K, Akita T, et al. Determination of trace amounts of chiral amino acids in complicated biological samples using two-dimensional high-performance liquid chromatography with an innovative “shape-fitting” peak identification/quantification method. Chromatography. 2018;39:147–52.
Cameron JS. Lupus nephritis. J Am Soc Nephrol. 1999;10:413–24.
Miya K, Inoue R, Takata Y, Abe M, Natsume R, Sakimura K, et al. Serine racemase is predominantly localized in neurons in mouse brain. J Comp Neurol. 2008;510:641–54.
Sasabe J, Miyoshi Y, Rakoff-Nahoum S, Zhang T, Mita M, Davis BM, et al. Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota. Nature Microbiology. 2016;1:16125.
Nakade Y, Iwata Y, Furuichi K, Mita M, Hamase K, Konno R, et al. Gut microbiota-derived d-serine protects against acute kidney injury. JCI Insight. 2018;3:e97957.
Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2:445–53.